About

Gene Editing in Focus

By Maggie Wright

~6 minutes


Advancements in genetic engineering have brought revolutionary tools to the forefront of biotechnology, with CRISPR leading as one of the most precise and cost-effective methods of gene editing. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, allows scientists to alter DNA sequences by targeting specific sections of the genome. Originally discovered as part of a bacterial immune system, CRISPR systems have now been adapted to serve as programmable gene-editing platforms. This paper explores how CRISPR works, its current uses, its future potential, and the ethical considerations surrounding its application in both human and non-human systems.

How CRISPR System Works

The CRISPR-Cas system operates by combining a specially designed RNA molecule with a CRISPR-associated protein, such as Cas9 or Cas12a. The RNA guides the protein to a specific sequence in the genome, where the protein then cuts the DNA. Once the strand is cut, natural repair mechanisms within the cell are activated. Researchers can either allow the cell to disable the gene or insert a new gene into the gap. As described by researchers at Stanford University,

“The system is remarkably versatile, allowing scientists to silence genes, replace defective segments, or even insert entirely new sequences.” (CRISPR Gene Editing and Beyond)

This mechanism has been compared to a pair of molecular scissors that can cut with precision. For example, the Cas9 protein is programmed with a guide RNA to recognize a DNA sequence of about 20 nucleotides. Once it finds the target, it makes a double-stranded cut. The repair process that follows enables gene knockouts, insertions, or corrections. This technology has dramatically reduced the time and cost associated with gene editing, making previously complex tasks achievable in weeks rather than months. According to a 2020 review,

“CRISPR/Cas9 offers researchers a user-friendly, relatively inexpensive, and highly efficient method for editing the genome.” (Computational Tools and Resources Supporting CRISPR-Cas Experiments)

A simple guide to CRISPR / Javier Zarracina / Vox ©

CRISPR’s Application in Medicine

CRISPR’s influence extends across many fields, but its role in medicine has attracted the most attention. Scientists are using CRISPR to treat genetic diseases such as sickle cell anemia by editing patients’ own stem cells outside the body and then reinserting them. In 2023, researchers published results showing that a single treatment could permanently alleviate symptoms for some patients with these genetic diseases (Zhang 4.) Another area of exploration includes its potential for treating cancers by modifying immune cells to better recognize and destroy cancerous tissue. According to Molecular Cancer,

“Gene editing technologies have successfully demonstrated the correction of mutations in hematopoietic stem cells, offering hope for long-term cures.” (Zhang 3)

Current gene-editing uses / Royal Society ©

CRISPR in Agriculture

Beyond human health, CRISPR has transformed agricultural practices. Scientists are using it to develop crops that resist pests, drought, or disease without the need for traditional genetic modification methods that insert foreign DNA. One of the longer processes of traditional modifications in DNA could include conjugation. This is moving genetic material through bacterial cells in a direct contact. Conjugation is just one example of many of the traditional genetic modification methods.

CRISPR has been used to produce tomatoes with longer shelf lives and rice varieties that can survive in low-water environments. According to the World Economic Forum,

“CRISPR can help build food security by making crops more resilient and nutritious.” (CRISPR Gene Editing for a Better World)

Such developments are increasingly critical in addressing global food demands and climate challenges.

Research is also underway to apply CRISPR in animal breeding and disease control. In mosquitoes, scientists are testing ways to spread genes that reduce malaria transmission. In livestock, researchers are working to produce animals that are more resistant to disease. These experiments, while promising, require cautious monitoring to ensure ecosystem stability and safety.

Future Potential

Looking ahead, new techniques are refining CRISPR’s capabilities. Base editing allows researchers to change a single letter of DNA without cutting the strand entirely, reducing the off-targeting effect such as prime editing, a newer method that uses an engineered protein to insert new genetic material without causing double-stranded breaks. These tools provide even more control. According to the Stanford report,

“Prime editing may become the preferred approach for correcting single-point mutations, which are responsible for many inherited diseases.” (CRISPR Gene Editing and Beyond)

Possible Concerns

Despite its potential, CRISPR also raises important ethical concerns. One of the most debated topics is germline editing, or the modification of genes in human embryos or reproductive cells. Changes made at this level can be passed down to future generations, leading to unknown consequences. In 2018, the birth of twin girls in China following germline editing sparked international outrage and led to widespread calls for stricter regulation. The scientific community responded swiftly, with many organizations calling for a global prohibition on clinical germline editing. As CRISPR & Ethics – Innovative Genomics Institute (IGI) states,

“Without clear guidelines, genome editing can rapidly veer into ethically gray areas, particularly in germline applications.”

Another concern is the potential for unintended consequences, known as off-target effects. These are accidental changes to parts of the genome that were not intended to be edited, which could lead to harmful mutations or unforeseen health problems. I will expand on this later in the article. Researchers are actively developing tools to better predict and detect such errors, but long-term safety remains a topic of study. The possibility of using CRISPR for non-therapeutic purposes, such as enhancing physical or cognitive traits.

Cost and accessibility are also significant factors. Although the CRISPR tools themselves are affordable for research institutions, the cost of CRISPR-based therapies remains high. According to Integrated DNA Technologies,

“Therapies based on CRISPR currently cost hundreds of thousands of dollars per patient, limiting their availability.” (CRISPR-Cas9: Pros and Cons)

Bridging this gap requires investments in infrastructure, policy development, and global partnerships to ensure that developing countries are not left behind.

In conclusion, CRISPR is reshaping the landscape of genetics and biotechnology. It has already brought major advances to medicine, agriculture, and environmental science. While the technology is still evolving, its precision offers a glimpse into the future of human health. CRISPR the potential to unlock solutions to some of humanity’s most pressing challenges.


References

“5 Novel Uses of CRISPR Gene Editing.” Genetic Engineering & Biotechnology News, http://www.genengnews.com/topics/genome-editing/5-novel-uses-of-crispr-gene-editing. Accessed 31 July 2025.
“CRISPR Gene Editing and Beyond.” Stanford News, Stanford University, 2024, news.stanford.edu/stories/2024/06/stanford-explainer-crispr-gene-editing-and-beyond. Accessed 31 July 2025.
“CRISPR-Cas9 Gene Editing.” Broad Institute of MIT and Harvard, http://www.broadinstitute.org/news/crispr-cas9-gene-editing-explained. Accessed 31 July 2025.
“CRISPR Gene Editing for a Better World.” World Economic Forum, 2024, www.weforum.org/stories/2024/04/crispr-gene-editing-better-world. Accessed 31 July 2025.
“CRISPR-Cas9: What Are the 10 Pros and 7 Cons?” IDT DNA, Integrated DNA Technologies, www.idtdna.com/pages/community/blog/post/crispr-cas9-what-are-the-10-pros-and-7-cons. Accessed 31 July 2025.
“Current Gene Editing Uses.” National Human Genome Research Institute, http://www.genome.gov/about-genomics/fact-sheets/Genome-Editing. Accessed 31 July 2025.
Lino, Cathryn A., et al. “Delivering CRISPR: A Review of Methods and Applications.” Drug Delivery and Translational Research, vol. 8, no. 1, 2020, pp. 1–14. PubMed Central, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427626/. Accessed 31 July 2025.
Zhang, Yujing, et al. “Gene Editing in Cancer: Opportunities and Challenges.” Molecular Cancer, vol. 22, no. 48, 2023, https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-023-01925-5. Accessed 31 July 2025.

Comments

Leave a comment